NCT04041778View on ClinicalTrials.gov

'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Atrial Fibrillation MechanismsPersistent Atrial FibrillationSubstrate AblationPulmonary Vein IsolationNon-contact Mapping
Interventions
OTHER

Catheter ablation

Substrate ablation. Pulmonary vein isolation.

Trial Locations (1)

LE3 9QP

University Hospitals Leicester NHS Foundation Trust, Glenfield Hospital, Leicester

All Listed Sponsors
lead

University of Leicester

OTHER

NCT04041778 - 'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)' | Biotech Hunter | Biotech Hunter